Pages that link to "Q40158851"
Jump to navigation
Jump to search
The following pages link to Alpha1-antitrypsin protects beta-cells from apoptosis (Q40158851):
Displaying 50 items.
- Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experience (Q26850621) (← links)
- Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats (Q26858837) (← links)
- Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes (Q26861561) (← links)
- Expanding the clinical indications for α(1)-antitrypsin therapy (Q27000764) (← links)
- Splicing variants of SERPINA1 gene in ovine milk: characterization of cDNA and identification of polymorphisms (Q28535592) (← links)
- Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats (Q33671373) (← links)
- The discovery of α1-antitrypsin and its role in health and disease (Q34025923) (← links)
- Efforts to prevent and halt autoimmune beta cell destruction (Q34077363) (← links)
- α-1-Antitrypsin and IFN-γ reduce the severity of IC-mediated vasculitis by regulation of leukocyte recruitment in vivo. (Q34264012) (← links)
- A review of augmentation therapy for alpha-1 antitrypsin deficiency (Q34268108) (← links)
- Retracted: The Immunoregulation Effect of Alpha 1-Antitrypsin Prolong β-Cell Survival after Transplantation (Q35145461) (← links)
- Elastase inhibitory activity of airway α1-antitrypsin is protected by treatment with a catalytic antioxidant in a baboon model of severe bronchopulmonary dysplasia. (Q35194438) (← links)
- α-1-Antitrypsin Gene Delivery Reduces Inflammation, Increases T-Regulatory Cell Population Size and Prevents Islet Allograft Rejection (Q35286904) (← links)
- Acute-phase protein α1-antitrypsin inhibits neutrophil calpain I and induces random migration (Q35286977) (← links)
- Comparative proteomic study reveals the molecular aspects of delayed ocular symptoms induced by sulfur mustard (Q35562012) (← links)
- Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation (Q35673668) (← links)
- Scavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cells (Q35959814) (← links)
- Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus (Q36032325) (← links)
- Interaction of dendritic cells and T lymphocytes for the therapeutic effect of Dangguiliuhuang decoction to autoimmune diabetes (Q36049534) (← links)
- Alpha 1-antitrypsin reduces inflammation and enhances mouse pancreatic islet transplant survival (Q36280053) (← links)
- Antiaging Gene Klotho Attenuates Pancreatic β-Cell Apoptosis in Type 1 Diabetes (Q36311562) (← links)
- Antibody Response to Serpin B13 Induces Adaptive Changes in Mouse Pancreatic Islets and Slows Down the Decline in the Residual Beta Cell Function in Children with Recent Onset of Type 1 Diabetes Mellitus (Q36419249) (← links)
- Insulin Degradation by Acinar Cell Proteases Creates a Dysfunctional Environment for Human Islets Before/After Transplantation: Benefits of α-1 Antitrypsin Treatment (Q36655234) (← links)
- Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells (Q36830558) (← links)
- Effect of recombinant α1-antitrypsin Fc-fused (AAT-Fc)protein on the inhibition of inflammatory cytokine production and streptozotocin-induced diabetes (Q36885672) (← links)
- alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice (Q36935759) (← links)
- Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. (Q36945031) (← links)
- Allogeneic islet transplantation (Q36981652) (← links)
- Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood (Q37159126) (← links)
- Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase (Q37173117) (← links)
- Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells (Q37372512) (← links)
- The role of augmentation therapy in alpha-1 antitrypsin deficiency (Q37827852) (← links)
- α(1)-antitrypsin deficiency and inflammation (Q37855954) (← links)
- Towards cytoprotection in the peritransplant period (Q37920330) (← links)
- Alpha-1 Antitrypsin: A Potent Anti-Inflammatory and Potential Novel Therapeutic Agent (Q37986292) (← links)
- Immune-modulating effects of alpha-1 antitrypsin (Q38214040) (← links)
- Innate immunity for better or worse govern the allograft response (Q38309267) (← links)
- Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option? (Q38365800) (← links)
- The multiple facets of alpha-1-antitrypsin (Q38553419) (← links)
- Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions (Q38711081) (← links)
- Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015). (Q38769762) (← links)
- Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development (Q38806457) (← links)
- Immune protective effect of human alpha-1-antitrypsin gene during β cell transplantation in diabetic mice (Q38899884) (← links)
- Implications for the offspring of circulating factors involved in beta cell adaptation in pregnancy (Q38956452) (← links)
- Utilization of Positive and Negative Controls to Examine Comorbid Associations in Observational Database Studies (Q39244414) (← links)
- Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases (Q39412031) (← links)
- α-Linoleic acid enhances the capacity of α-1 antitrypsin to inhibit lipopolysaccharide-induced IL-1β in human blood neutrophils (Q39565971) (← links)
- Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model (Q39587262) (← links)
- Thiazolidinediones protect mouse pancreatic β-cells directly from cytokine-induced cytotoxicity through PPARγ-dependent mechanisms (Q39620625) (← links)
- Reg2 protects mouse insulinoma cells from streptozotocin-induced mitochondrial disruption and apoptosis (Q39648361) (← links)